BioBridges Conference

We are a non-profit platform that encourages open dialogue among professionals in bioequivalence and pharmaceutical development. Our founders, Professor Jean-Michel Cardot, Professor Ondřej Slanař, Ing. Helmut Schütz, and Dr. Vít Perlík established this platform in 2016. However, all started way before as a small and informal gathering of only several people from the regulatory world, academia and industry with the aim of filling the much-needed niche of a cost-friendly gathering of drug development and regulatory professionals, where ideas and opinions can be freely shared. As the topics and scope expanded, so did the interest from a wider circle of audience. With each coming year, the attendance grew, reaching up to two hundred guests. Today, BioBridges is a welcoming space for industry experts, regulators, and scientists to engage in open discussions about important regulatory and drug development topics. These topics include concept papers, draft guidelines, and guidelines that may impact future development efforts and regulatory lives. New approaches to drug development, successful and unsuccessful case studies are shared, all with the same vision: to facilitate communication among regulators, industry and research, and help to create space for more efficient drug development. Great speakers and interesting topics Throughout the years, BioBridges has had the pleasure of hosting a number of distinguished speakers from various backgrounds including industry, universities, and regulatory agencies. Some of these notable speakers include Henrike Potthast, Milena Stain, Barbara Davit, René Anour, Bruno Sepodes, Steffen Thirstrup, Paulo Paixão, and many others.